Sample Analysis (Snake Venom)
Estimated value
—
Awarded value
£245k
Suppliers
1
Lots
1
Published
21 Jan 2026
Description
The purpose of this project is to evaluate efficacy and safety of a range of existing and new antivenoms with, developing evidence for policy-makers on the optimum antivenoms for their countries. This tender will cover the analysis of the clinical samples collected during the ANYSNAKES trial. In addition to this a subset of samples will be part of our trial looking at small molecule which can inhibit venom (TOCSINS). This procurement is intended to establish a supplier relationship that can support the initial study described, as well as future studies of a similar nature that may arise during the contract period. Each additional study will be confirmed through an agreed task order or variation. To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=994462286
Scope
- Reference
- LW150
- Commercial tool
- Standalone contract
- Contract dates
- 30 Nov 2025 to 29 Nov 2028Possible extension to 29 Nov 2030
2 Options to extend the contract for periods of one year each
- CPV classifications
- 7162000085111810
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| As stated in Tender documentation | — | price | 30.00% |
| As stated in Tender documentation | — | quality | 70.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£245k
Award date
21 Jan 2026
Contract start
04 Feb 2026
Contract end
31 Jan 2029